As of April 2023, states can end Medicaid coverage for individuals deemed ineligible through a process called “unwinding.” This has disrupted access to medications for many Americans, including children, affecting treatment for conditions like asthma and behavioral health disorders—and, in turn, their daily functioning. With states varying in how they implement the process, the effects differ widely. Kao-Ping Chua, M.D., Ph.D., director of U-M’s Susan B. Meister Child Health Evaluation and Research Center, explains the impact of Medicaid unwinding.
